150 related articles for article (PubMed ID: 20001236)
21. [Assessment of selected markers of apoptosis and angiogenesis in chronic lymphocytic leukemia].
Motyčková M; Smolej L; Andrýs C; Rezáčová V; Reháček V; Simkovič M; Belada D; Zák P
Vnitr Lek; 2013 Sep; 59(9):782-93. PubMed ID: 24073950
[TBL] [Abstract][Full Text] [Related]
22. HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?
Erikci AA; Karagoz B; Ozyurt M; Ozturk A; Kilic S; Bilgi O
Hematology; 2009 Apr; 14(2):101-5. PubMed ID: 19298722
[TBL] [Abstract][Full Text] [Related]
23. High Bax/Bcl-2 ratio is associated with good prognosis and better survival in patients with B cell chronic lymphocytic leukemia.
Helaly NA; Esheba NE; Ammo DEA; Elwan NM; Elkholy RA
Leuk Res; 2021 Aug; 107():106604. PubMed ID: 33965850
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
[TBL] [Abstract][Full Text] [Related]
25. Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients.
Monserrat J; Sánchez MÁ; de Paz R; Díaz D; Mur S; Reyes E; Prieto A; de la Hera A; Martínez-A C; Alvarez-Mon M
Cytometry B Clin Cytom; 2014 Jan; 86(1):32-43. PubMed ID: 24166938
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of ZAP-70 and CD 38 in Indian chronic lymphocytic leukemia patients.
Gogia A; Sharma A; Raina V; Kumar L; Gupta R; Kumar R
Indian J Cancer; 2013; 50(4):333-6. PubMed ID: 24369212
[TBL] [Abstract][Full Text] [Related]
27. ZAP-70 protein expression in B-cell chronic lymphoid leukemia: a single center experience from Pakistan.
Zeeshan R; Irfan SM; Sultan S; Bhimani S
Asian Pac J Cancer Prev; 2015; 16(4):1587-90. PubMed ID: 25743836
[TBL] [Abstract][Full Text] [Related]
28. ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations.
Zucchetto A; Bomben R; Bo MD; Nanni P; Bulian P; Rossi FM; Del Principe MI; Santini S; Del Poeta G; Degan M; Gattei V
Cytometry B Clin Cytom; 2006 Jul; 70(4):284-92. PubMed ID: 16906587
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia.
Del Principe MI; Del Poeta G; Venditti A; Buccisano F; Maurillo L; Marini R; Cox MC; Panetta P; Suppo G; Degan M; Bruno A; Gattei V; Amadori S
Haematologica; 2004 Dec; 89(12):1468-75. PubMed ID: 15590397
[TBL] [Abstract][Full Text] [Related]
30. Discordant results of flow cytometric ZAP-70 expression status in B-CLL samples if different gating strategies are applied.
Wilhelm C; Neubauer A; Brendel C
Cytometry B Clin Cytom; 2006 Jul; 70(4):242-50. PubMed ID: 16906574
[TBL] [Abstract][Full Text] [Related]
31. Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL).
Faderl S; Keating MJ; Do KA; Liang SY; Kantarjian HM; O'Brien S; Garcia-Manero G; Manshouri T; Albitar M
Leukemia; 2002 Jun; 16(6):1045-52. PubMed ID: 12040436
[TBL] [Abstract][Full Text] [Related]
32. Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia.
Bosch F; Muntañola A; Giné E; Carrió A; Villamor N; Moreno C; Crespo M; Montserrat E
Cytometry B Clin Cytom; 2006 Jul; 70(4):214-7. PubMed ID: 16906580
[TBL] [Abstract][Full Text] [Related]
33. THE PROGNOSTIC SIGNIFICANCE OF COMBAIND EXPRESSION OF ZAP-70 AND CD38 IN CHRONIC LYMPHOCYTIC LEUKEMIA.
Kirtava T; Vatsadze T; Azrmaiparashili E; Ghirdaladze D
Georgian Med News; 2017 Jun; (267):12-16. PubMed ID: 28726646
[TBL] [Abstract][Full Text] [Related]
34. Differential control of G0 programme in chronic lymphocytic leukaemia: a novel prognostic factor.
Danilov AV; Klein AK; Lee HJ; Baez DV; Huber BT
Br J Haematol; 2005 Feb; 128(4):472-81. PubMed ID: 15686454
[TBL] [Abstract][Full Text] [Related]
35. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
[TBL] [Abstract][Full Text] [Related]
36. Variations in the detection of ZAP-70 in chronic lymphocytic leukemia: Comparison with IgV(H) mutation analysis.
Sheikholeslami MR; Jilani I; Keating M; Uyeji J; Chen K; Kantarjian H; O'Brien S; Giles F; Albitar M
Cytometry B Clin Cytom; 2006 Jul; 70(4):270-5. PubMed ID: 16906585
[TBL] [Abstract][Full Text] [Related]
37. CD40 ligand, Bcl-2 and apoptosis in B-chronic lymphocytic leukemia.
Hussein OA; Omran AA; Elnaggar AM; Fathy A
Egypt J Immunol; 2009; 16(2):27-36. PubMed ID: 22059351
[TBL] [Abstract][Full Text] [Related]
38. Comparison of methods for determining zeta-chain associated protein - 70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL).
Bojarska-Junak A; Giannopoulos K; Kowal M; Dmoszyńska A; Roliński J
Cytometry B Clin Cytom; 2006 Jul; 70(4):293-301. PubMed ID: 16906577
[TBL] [Abstract][Full Text] [Related]
39. A robust ratio metric method for analysis of Zap-70 expression in chronic lymphocytic leukemia (CLL).
Bakke AC; Purtzer Z; Leis J; Huang J
Cytometry B Clin Cytom; 2006 Jul; 70(4):227-34. PubMed ID: 16342060
[TBL] [Abstract][Full Text] [Related]
40. Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.
Nückel H; Frey UH; Bau M; Sellmann L; Stanelle J; Dürig J; Jöckel KH; Dührsen U; Siffert W
Blood; 2007 Jan; 109(1):290-7. PubMed ID: 16960146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
